GlaxoSmithKline Pharmaceuticals Ltd. - Research Center
500660 GLAXO Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Cash flow
|
| More |
Cash flow
(Rs crore)
| Mar ' 24 | Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | |
|---|---|---|---|---|---|
| Profit before tax | 952.65 | 837.49 | 2,470.04 | 722.33 | 646.99 |
| Net cashflow-operating activity | 578.94 | 487.94 | 819.79 | 594.87 | 490.97 |
| Net cash used in investing activity | 14.97 | 805.19 | -419.66 | 407.57 | -63.10 |
| Netcash used in fin. activity | -561.50 | -1,544.18 | -524.24 | -695.56 | -427.62 |
| Net inc/dec in cash and equivlnt | 32.41 | -251.05 | -124.11 | 306.87 | 0.25 |
| Cash and equivalnt begin of year | 29.74 | 280.79 | 404.90 | 98.03 | 97.78 |
| Cash and equivalnt end of year | 62.15 | 29.74 | 280.79 | 404.90 | 98.03 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis